{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:28:11Z","timestamp":1788985691773,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,3]],"date-time":"2027-08-03T00:00:00Z","timestamp":1817251200000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jchf.2026.103151","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:22:22Z","timestamp":1779430942000},"page":"103151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Refining the Definition for \u201cLow Risk\u201d in Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6243-2544","authenticated-orcid":false,"given":"Charles","family":"Fauvel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla Correa","family":"Jaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Wan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0672-1680","authenticated-orcid":false,"given":"Sandeep","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson A.","family":"Villasmil Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Weatherald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Cascino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Perer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Matusov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-4491","authenticated-orcid":false,"given":"Shili","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-6236","authenticated-orcid":false,"given":"Raymond L.","family":"Benza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.jchf.2026.103151_bib1","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jchf.2026.103151_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01323-2024","article-title":"Risk stratification and treatment goals in pulmonary arterial hypertension","volume":"64","author":"Dardi","year":"2024","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jchf.2026.103151_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jchf.2026.103151_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02419-2021","article-title":"External validation of a refined 4-strata risk assessment score from the French Pulmonary Hypertension Registry","volume":"59","author":"Boucly","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jchf.2026.103151_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02311-2021","article-title":"COMPERA 2.0: a refined 4-strata risk assessment model for pulmonary arterial hypertension","volume":"60","author":"Hoeper","year":"2021","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jchf.2026.103151_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01129-2024","article-title":"Exploring the patient perspective in pulmonary hypertension","volume":"64","author":"Ford","year":"2024","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.jchf.2026.103151_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2017.12.010","article-title":"Pulmonary arterial hypertension-related morbidity is prognostic for mortality","volume":"71","author":"McLaughlin","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jchf.2026.103151_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.chest.2023.09.005","article-title":"Risk stratification in pulmonary arterial hypertension: perhaps simple is not best?","volume":"165","author":"Fauvel","year":"2024","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jchf.2026.103151_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01325-2024","article-title":"Treatment algorithm for pulmonary arterial hypertension","volume":"64","author":"Chin","year":"2024","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.jchf.2026.103151_bib10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.jchf.2026.103151_bib11","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jchf.2026.103151_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/rccm.201908-1640OC","article-title":"Combination therapy with oral treprostinil for pulmonary arterial hypertension. A double-blind placebo-controlled clinical trial","volume":"201","author":"White","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"26","key":"10.1016\/j.jchf.2026.103151_bib13","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jchf.2026.103151_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jchf.2026.103151_bib15","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jchf.2026.103151_bib16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jchf.2026.103151_bib17","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1183\/09031936.00116313","article-title":"Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study","volume":"43","author":"Sitbon","year":"2014","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jchf.2026.103151_bib18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jchf.2026.103151_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00889-2017","article-title":"Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.jchf.2026.103151_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/thorax-2022-219490","article-title":"Patients\u2019 perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy","volume":"78","author":"Mai","year":"2023","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jchf.2026.103151_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ejhf.2369","article-title":"The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study","volume":"24","author":"Rosenkranz","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jchf.2026.103151_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.chest.2024.03.002","article-title":"Atrial arrhythmias in patients with pulmonary hypertension","volume":"166","author":"O\u2019Meara","year":"2024","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jchf.2026.103151_bib23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jchf.2026.103151_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002302","article-title":"Continuous long-term heart rate variability and risk assessment in pulmonary hypertension","volume":"10","author":"Andersen","year":"2023","journal-title":"Open Heart"},{"key":"10.1016\/j.jchf.2026.103151_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.amjcard.2023.07.056","article-title":"Heart rate response predicts 6-minutes walking distance in pulmonary arterial hypertension","volume":"204","author":"Lu","year":"2023","journal-title":"Am J Cardiol"},{"issue":"36","key":"10.1016\/j.jchf.2026.103151_bib26","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jchf.2026.103151_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12317","article-title":"Real-world evidence to advance knowledge in pulmonary hypertension: status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute\u2019s Innovative Drug Development Initiative\u2019s Real-world Evidence Working Group","volume":"13","author":"Morland","year":"2023","journal-title":"Pulm Circ"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926002519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926002519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:42:02Z","timestamp":1785782522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177926002519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2213177926002519"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103151","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refining the Definition for \u201cLow Risk\u201d in Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}],"article-number":"103151"}}